J.Molner AS (OTSE:MOLNR) Asset Impairment Charge : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Asset Impairment Charge?

J.Molner AS's Asset Impairment Charge for the six months ended in Dec. 2023 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

J.Molner AS Asset Impairment Charge Historical Data

The historical data trend for J.Molner AS's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Asset Impairment Charge Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Asset Impairment Charge

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Asset Impairment Charge	-	-	-	-	-

J.Molner AS Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

J.Molner AS Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Asset Impairment Charge

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines